Taken together, these data suggest that circulating intact FGF23 is also associated with adverse outcomes in feline and canine CKD patients similar to humans (Geddes et al., 2013, 2015; Harjes et al., 2017). This evidence concerns the gene FGF23 and chronic kidney disease.